Phase I trial and pharmacokinetics of the tubulin inhibitor 1069C85--a synthetic agent binding at the colchicine site designed to overcome multidrug resistance.
about
Phase I trial and pharmacokinetics of the tubulin inhibitor 1069C85--a synthetic agent binding at the colchicine site designed to overcome multidrug resistance.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Phase I trial and pharmacokine ...... overcome multidrug resistance.
@ast
Phase I trial and pharmacokine ...... overcome multidrug resistance.
@en
type
label
Phase I trial and pharmacokine ...... overcome multidrug resistance.
@ast
Phase I trial and pharmacokine ...... overcome multidrug resistance.
@en
prefLabel
Phase I trial and pharmacokine ...... overcome multidrug resistance.
@ast
Phase I trial and pharmacokine ...... overcome multidrug resistance.
@en
P2093
P2860
P356
P1476
Phase I trial and pharmacokine ...... overcome multidrug resistance
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1997.107
P407
P50
P577
1997-01-01T00:00:00Z